IBB
$202.64iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense ratio
0.44%
Dividend yield
0.20%
AUM
$10.47B
Issuer
iShares
YTD return
22.95%
1Y return
—
5Y return
—
10Y return
—
Top holdings
Top holdings · IBB
| AMGN | Amgen Inc | 8.45% |
| VRTX | Vertex Pharmaceuticals Inc | 8.06% |
| GILD | Gilead Sciences Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 5.72% |
| MRNA | Moderna Inc | 3.62% |
| NTRA | Natera Inc | 3.12% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| ILMN | Illumina Inc | 2.29% |
| ALNY | Alnylam Pharmaceuticals Inc | 2.27% |
Sector exposure
Sector breakdown · IBB
Healthcare100.0%